Monika Szelest1, Martyna Stefaniak1, Gabriela Ręka1, Ilona Jaszczuk2, Monika Lejman3. 1. Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, Gębali 6, 20-093, Lublin, Poland. 2. Department of Cancer Genetics With Cytogenetics Laboratory, Medical University of Lublin, Radziwiłłowska 11, 20-080, Lublin, Poland. 3. Laboratory of Genetic Diagnostics, Medical University of Lublin, A. Gębali 6, 20-093, Lublin, Poland. lejmanm@poczta.onet.pl.
Abstract
BACKGROUND: 16p11.2 microdeletion is a known chromosomal anomaly associated mainly with neurocognitive developmental delay, predisposition to obesity, and variable dysmorphism. Although this deletion is relatively rare among the general population, it is one of the serious known genetic aetiologies of obesity and autism spectrum disorder. CASE PRESENTATION: This study presents three cases of deletions within the 16p11.2 region. Every child had mild variable craniofacial abnormalities, hand or foot anomalies and developmental and language delays. The first proband had obesity, epilepsy, moderate intellectual disability, aphasia, motor delay, hyperinsulinism, and café au lait spots. The second proband suffered from cardiac, pulmonary, and haematological problems. The third proband had motor and language delays, bronchial asthma, and umbilical hernia. Although each patient presented some features of the syndrome, the children differed in terms of their clinical pictures. Genetic diagnosis of 16p11.2 microdeletion syndrome was made in children at different ages based on multiplex ligation probe-dependent amplification analysis and/or microarray methods. CONCLUSIONS: Our reports allow us to analyse and better understand the biology of 16p11.2 microdeletion throughout development. However, the variability of presented cases supports the alternate conclusion to this presented in available literature regarding 16p11.2 deletion, as we observed no direct cause-and-effect genotype/phenotype relationships. The reported cases indicate the key role of the interdisciplinary approach in 16p11.2 deletion diagnostics. The care of patients with this anomaly is based on regular health assessment and adjustment of nervous system development therapy.
BACKGROUND: 16p11.2 microdeletion is a known chromosomal anomaly associated mainly with neurocognitive developmental delay, predisposition to obesity, and variable dysmorphism. Although this deletion is relatively rare among the general population, it is one of the serious known genetic aetiologies of obesity and autism spectrum disorder. CASE PRESENTATION: This study presents three cases of deletions within the 16p11.2 region. Every child had mild variable craniofacial abnormalities, hand or foot anomalies and developmental and language delays. The first proband had obesity, epilepsy, moderate intellectual disability, aphasia, motor delay, hyperinsulinism, and café au lait spots. The second proband suffered from cardiac, pulmonary, and haematological problems. The third proband had motor and language delays, bronchial asthma, and umbilical hernia. Although each patient presented some features of the syndrome, the children differed in terms of their clinical pictures. Genetic diagnosis of 16p11.2 microdeletion syndrome was made in children at different ages based on multiplex ligation probe-dependent amplification analysis and/or microarray methods. CONCLUSIONS: Our reports allow us to analyse and better understand the biology of 16p11.2 microdeletion throughout development. However, the variability of presented cases supports the alternate conclusion to this presented in available literature regarding 16p11.2 deletion, as we observed no direct cause-and-effect genotype/phenotype relationships. The reported cases indicate the key role of the interdisciplinary approach in 16p11.2 deletion diagnostics. The care of patients with this anomaly is based on regular health assessment and adjustment of nervous system development therapy.
Authors: Ian Blumenthal; Ashok Ragavendran; Serkan Erdin; Lambertus Klei; Aarathi Sugathan; Jolene R Guide; Poornima Manavalan; Julian Q Zhou; Vanessa C Wheeler; Joshua Z Levin; Carl Ernst; Kathryn Roeder; Bernie Devlin; James F Gusella; Michael E Talkowski Journal: Am J Hum Genet Date: 2014-06-05 Impact factor: 11.025
Authors: Erin B Kaminsky; Vineith Kaul; Justin Paschall; Deanna M Church; Brian Bunke; Dawn Kunig; Daniel Moreno-De-Luca; Andres Moreno-De-Luca; Jennifer G Mulle; Stephen T Warren; Gabriele Richard; John G Compton; Amy E Fuller; Troy J Gliem; Shuwen Huang; Morag N Collinson; Sarah J Beal; Todd Ackley; Diane L Pickering; Denae M Golden; Emily Aston; Heidi Whitby; Shashirekha Shetty; Michael R Rossi; M Katharine Rudd; Sarah T South; Arthur R Brothman; Warren G Sanger; Ramaswamy K Iyer; John A Crolla; Erik C Thorland; Swaroop Aradhya; David H Ledbetter; Christa L Martin Journal: Genet Med Date: 2011-09 Impact factor: 8.822
Authors: Carly Demopoulos; Hardik Kothare; Danielle Mizuiri; Jennifer Henderson-Sabes; Brieana Fregeau; Jennifer Tjernagel; John F Houde; Elliott H Sherr; Srikantan S Nagarajan Journal: Sci Rep Date: 2018-01-19 Impact factor: 4.996
Authors: Lucilla Pizzo; Matthew Jensen; Andrew Polyak; Jill A Rosenfeld; Katrin Mannik; Arjun Krishnan; Elizabeth McCready; Olivier Pichon; Cedric Le Caignec; Anke Van Dijck; Kate Pope; Els Voorhoeve; Jieun Yoon; Paweł Stankiewicz; Sau Wai Cheung; Damian Pazuchanics; Emily Huber; Vijay Kumar; Rachel L Kember; Francesca Mari; Aurora Curró; Lucia Castiglia; Ornella Galesi; Emanuela Avola; Teresa Mattina; Marco Fichera; Luana Mandarà; Marie Vincent; Mathilde Nizon; Sandra Mercier; Claire Bénéteau; Sophie Blesson; Dominique Martin-Coignard; Anne-Laure Mosca-Boidron; Jean-Hubert Caberg; Maja Bucan; Susan Zeesman; Małgorzata J M Nowaczyk; Mathilde Lefebvre; Laurence Faivre; Patrick Callier; Cindy Skinner; Boris Keren; Charles Perrine; Paolo Prontera; Nathalie Marle; Alessandra Renieri; Alexandre Reymond; R Frank Kooy; Bertrand Isidor; Charles Schwartz; Corrado Romano; Erik Sistermans; David J Amor; Joris Andrieux; Santhosh Girirajan Journal: Genet Med Date: 2018-09-07 Impact factor: 8.822
Authors: Karen Crawford; Matthew Bracher-Smith; David Owen; Kimberley M Kendall; Elliott Rees; Antonio F Pardiñas; Mark Einon; Valentina Escott-Price; James T R Walters; Michael C O'Donovan; Michael J Owen; George Kirov Journal: J Med Genet Date: 2018-10-20 Impact factor: 6.318
Authors: Laura J Stoppel; Tatiana M Kazdoba; Melanie D Schaffler; Anthony R Preza; Arnold Heynen; Jacqueline N Crawley; Mark F Bear Journal: Neuropsychopharmacology Date: 2017-10-06 Impact factor: 7.853